Training and Resources

GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)

GARDASIL® 9 is indicated for active immunisation of individuals from the age of 9 years against the following HPV diseases: Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine HPV types; Genital warts (Condyloma acuminata) caused by specific HPV types.

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

Supporting documentation

GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website